Author

Shu-Yi Wang

h-index 9 View on Semantic Scholar

We have 1 of 16 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Jul 2026

Efficacy and safety of SGLT2 inhibitors in elderly patients with type 2 diabetes

In elderly patients with type 2 diabetes, SGLT2 inhibitors demonstrate significant renal protective effects, particularly among those with preserved renal function (eGFR ≥50 mL/min/1.73 m2), suggesting greater benefit with early initiation of SGLT2 inhibitors for kidney protection.

Chieh-Sen Chuang, Chew-Teng Kor, Shu-Yi Wang et al. · Annals medicus · 0 citations